We have merged with Bristol Myers Squibb creating a leading biopharma company, ideally positioned to discover, develop and deliver innovative medicines for patients fighting serious diseases. Visit www.bms.com to learn more about our work to produce the next generation of medicines to treat cancer and other serious diseases. For more information on the acquisition, see our press release at: http://bit.ly/3UbQcnl
View Top Employees from Juno Therapeutics, Inc.| Website | http://www.bms.com |
| Ticker | NASDAQ:JUNO |
| Revenue | $111 million |
| Funding | $1.5 billion |
| Employees | 300 (300 on RocketReach) |
| Founded | 2013 |
| Address | 400 Dexter Ave N., Seattle, Washington 98109, US |
| Phone | (206) 582-1600 |
| Technologies |
JavaScript,
HTML,
Twitter
+88 more
(view full list)
|
| Category | Biotechnology, Biotechnology Research, Pharmaceuticals, Science and Engineering, Immunotherapy, Healthcare, Health Care, Drug Manufacturing & Research, Therapeutics, Wellness |
| Web Rank | 2 Million |
| Keywords | juno therapeutics, juno therapeutics car t zellen, car-t juno, juno, tcr reseptor |
| Competitors | Adaptimmune, CureVac, Dendreon, Kite Pharma, Sage Therapeutics |
| SIC | 28, 283 |
| NAICS | 541, 3254, 32541, 54, 5417, 32, 325 |
Looking for a particular Juno Therapeutics, Inc. employee's phone or email?
Juno Therapeutics, Inc. Questions
The Juno Therapeutics, Inc. annual revenue was $111 million in 2023.
Hyam Levitsky is the Executive Vice President Research, Chief Scientific Officer of Juno Therapeutics, Inc..
300 people are employed at Juno Therapeutics, Inc..
Juno Therapeutics, Inc. is based in Seattle, Washington.
The NAICS codes for Juno Therapeutics, Inc. are [541, 3254, 32541, 54, 5417, 32, 325].
The SIC codes for Juno Therapeutics, Inc. are [28, 283].
Top Juno Therapeutics, Inc. Employees
-
View
Hyam Levitsky
Executive Vice President Research, Chief Scientific Officer at Juno Therapeutics, Inc.
Seattle, Washington, United States15 -
12
-
ViewHyam Levitsky
Executive Vice President Research, Chief Scientific Officer at Juno Therapeutics, Inc.
Seattle, Washington, United States13 -
ViewLothar Germeroth
SVP, Managing Director Juno Therapeutics GmbH at Juno Therapeutics, Inc.
Göttingen, NDS, DE11 -
View
Lauren Ross
Associate Director, Strategic Sourcing and External Manufacturing, Cell Therapy at Juno Therapeutics, Inc.
California, United States24 -
22
Related Companies
